Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Granger

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|October 15, 1996
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.
The American Journal of Cardiology|November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE InvestigatorsB M Scirica, D J Moliterno, N R Every, et al.
Annals of Human Genetics|October 19, 2006
Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5qS H Shah, W E Kraus, D C Crossman, et al.
Circulation|May 11, 1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT InvestigatorsK W Mahaffey, R A Harrington, M L Simoons, et al.
Journal of the American College of Cardiology|November 30, 1999
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trialK W Mahaffey, J A Puma, N A Barbagelata, et al.
Heart (British Cardiac Society)|March 12, 2008
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationR D Lopes, K S Pieper, J R Horton, et al.
European Heart Journal|August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryB A Bart, G Ertl, P Held, et al.
American Heart Journal|March 31, 2000
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitorsC B Granger, G Ertl, J Kuch, et al.
European Heart Journal|February 27, 2004
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromesM T Roe, K W Mahaffey, R Kilaru, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|October 15, 1996
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.
The American Journal of Cardiology|November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE InvestigatorsB M Scirica, D J Moliterno, N R Every, et al.
Annals of Human Genetics|October 19, 2006
Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5qS H Shah, W E Kraus, D C Crossman, et al.
Circulation|May 11, 1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT InvestigatorsK W Mahaffey, R A Harrington, M L Simoons, et al.
Journal of the American College of Cardiology|November 30, 1999
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trialK W Mahaffey, J A Puma, N A Barbagelata, et al.
Heart (British Cardiac Society)|March 12, 2008
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationR D Lopes, K S Pieper, J R Horton, et al.
European Heart Journal|August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryB A Bart, G Ertl, P Held, et al.
American Heart Journal|March 31, 2000
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitorsC B Granger, G Ertl, J Kuch, et al.
European Heart Journal|February 27, 2004
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromesM T Roe, K W Mahaffey, R Kilaru, et al.
Pageof 14